|
KMID : 1132720210190010006
|
|
Genomics & Informatics
2021 Volume.19 No. 1 p.6 ~ p.6
|
|
|
Screening of novel alkaloid inhibitors for vascular endothelial growth factor in cancer cells: an integrated computational approach
|
|
Shahik Shah Md.
Salauddin Asma
Hossain Md. Shakhawat
Noyon Sajjad Hossain
Moin Abu Tayab
Mizan Shagufta
Raza Md. Thosif
|
|
|
Abstract
|
|
|
|
Vascular endothelial growth factor (VEGF) is expressed at elevated levels by most cancer cells, which can stimulate vascular endothelial cell growth, survival, proliferation as well as trigger angiogenesis modulated by VEGF and VEGFR (a tyrosine kinase receptor) signaling. The angiogenic effects of the VEGF family are thought to be primarily mediated through the interaction of VEGF with VEGFR-2. Targeting this signaling molecule and its receptor is a novel approach for blocking angiogenesis. In recent years virtual high throughput screening has emerged as a widely accepted powerful technique in the identification of novel and diverse leads. The high-resolution X-ray structure of VEGF has paved the way to introduce new small molecular inhibitors by structure-based virtual screening. In this study using different alkaloid molecules as potential novel inhibitors of VEGF, we proposed three alkaloid candidates for inhibiting VEGF and VEGFR mediated angiogenesis. As these three alkaloid compounds exhibited high scoring functions, which also highlights their high binding ability, it is evident that these alkaloids can be taken to further drug development pipelines for use as novel lead compounds to design new and effective drugs against cancer.
|
|
|
KEYWORD
|
|
|
alkaloids, angiogenesis, cancer, drug-likeness, molecular docking, vascular endothelial growth factor, virtual screening
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|